Loading...
Loading...
Among the 5 tracked institutional investors we monitor, NVCT (NUVECTIS PHARMA INC) is held with a combined value of $14.24M across 1,862,452 shares. The largest holder is VANGUARD GROUP INC with a position worth $6.38M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$14.24M
Total Shares Held
1,862,452
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $6.38M | 0.00% | New |
| 2 | BlackRock, Inc. | $5.91M | 0.00% | -2.3% |
| 3 | STATE STREET CORP | $1.29M | 0.00% | +7.7% |
| 4 | CITADEL ADVISORS LLC | $606.23K | 0.00% | -14.3% |
| 5 | FMR LLC | $58.50K | 0.00% | +5.0% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of NVCT with a position worth $6.38M, representing 0.00% of their portfolio. In total, 5 institutional investors hold NVCT with a combined value of $14.24M.
In the most recent quarter, 1 fund opened a new position in NVCT. Additionally, 2 increased their holdings and 2 reduced their positions.
Institutional investors hold $14.24M worth of NVCT stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $6.38M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NVCT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their NVCT positions.